accountrising, as we���ve reported . Today Bloomberg News highlights one disease for which that is especially true ��� multiple sclerosis, where the price of therapies rose by as much as 39% in 2010. The cost of those drugs is becoming similar to that of cancer...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to A.M. Vitals: Bristol-Myers Squibb���s Melanoma Drug Improves Survival
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account